Implementation Challenges for Risk-Stratified Screening in the Era of Precision Medicine
Open Access
- 1 November 2018
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 4 (11), 1484-1485
- https://doi.org/10.1001/jamaoncol.2018.1940
Abstract
Cancer screening tests are generally recommended when the benefits (eg, morbidity or mortality reduction) outweigh the risks (eg, overtreatment). In the era ofThis publication has 11 references indexed in Scilit:
- Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next StepsCancer Epidemiology, Biomarkers & Prevention, 2016
- Challenges and disparities in the application of personalized genomic medicine to populations with African ancestryNature Communications, 2016
- Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening GuidelinesJournal of General Internal Medicine, 2015
- Prediction of Breast Cancer Risk Based on Profiling With Common Genetic VariantsJNCI Journal of the National Cancer Institute, 2015
- Ethical, legal, and social implications of incorporating genomic information into electronic health recordsGenetics in Medicine, 2013
- Screening for breast cancer with mammographyEmergencias, 2013
- Incorporating genomics into breast and prostate cancer screening: assessing the implicationsGenetics in Medicine, 2013
- Multilevel Research and the Challenges of Implementing Genomic MedicineJNCI Monographs, 2012
- The Public's Response to the U.S. Preventive Services Task Force's 2009 Recommendations on Mammography ScreeningAmerican Journal of Preventive Medicine, 2011
- Impact of limited population diversity of genome-wide association studiesGenetics in Medicine, 2010